These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19032877)

  • 21. Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C.
    Yang JF; Dai CY; Chuang WL; Lin WY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
    Jpn J Infect Dis; 2006 Feb; 59(1):25-30. PubMed ID: 16495630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history: the importance of viral load, liver damage and HCC.
    Wursthorn K; Manns MP; Wedemeyer H
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1063-79. PubMed ID: 19187867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. StatBite: Reported cases of acute hepatitis infection in the United States.
    J Natl Cancer Inst; 2008 May; 100(10):697. PubMed ID: 18477797
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis.
    Hourigan LF; Macdonald GA; Purdie D; Whitehall VH; Shorthouse C; Clouston A; Powell EE
    Hepatology; 1999 Apr; 29(4):1215-9. PubMed ID: 10094967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B and C viral infections in chronic liver disease: a population based study in Qatar.
    Rikabi A; Bener A; Al-Marri A; Al-Thani S
    East Mediterr Health J; 2009; 15(4):778-84. PubMed ID: 20187528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver steatosis in children with chronic hepatitis C.
    Guido M; Bortolotti F; Jara P; Giacomelli L; Fassan M; Hierro L; Nebbia G; Zancan L; Rugge M
    Am J Gastroenterol; 2006 Nov; 101(11):2611-5. PubMed ID: 17090284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic steatosis in patients with chronic hepatitis C virus infection. Another risk factor for hepatocellular carcinoma?
    Zhu AX; Chung RT
    Cancer; 2003 Jun; 97(12):2948-50. PubMed ID: 12784328
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of serum leptin levels in chronic hepatitis C with steatosis.
    Ellidokuz E; Cömlekçi A; Ellidokuz H; Akpinar H; Gökçe C; Tankurt E; Sagol O; Simsek I; Gönen O
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxix-cclxxii. PubMed ID: 15244198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C and steatosis.
    Björnsson E; Angulo P
    Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
    Liu CJ; Jeng YM; Chen PJ; Lai MY; Yang HC; Huang WL; Kao JH; Chen DS
    Antivir Ther; 2005; 10(3):405-15. PubMed ID: 15918331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dynamics of the pathomorphological changes in cirrhotic liver in own material].
    Mietkiewski J
    Przegl Epidemiol; 2005; 59(2):411-4. PubMed ID: 16190548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C.
    Kumar D; Farrell GC; Kench J; George J
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1395-400. PubMed ID: 16105127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of extrahepatic illnesses in patients with chronic hepatitis b and hepatitis c: retrospective study of 435 patients].
    Cesur S; Akin K; Albayrak F; Birengel S; Kurt H; Balik I
    Mikrobiyol Bul; 2003; 37(2-3):187-93. PubMed ID: 14593902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steatosis and chronic hepatitis C virus infection: mechanisms and significance.
    Patel K; Zekry A; McHutchison JG
    Clin Liver Dis; 2005 Aug; 9(3):399-410, vi. PubMed ID: 16023973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
    Castera L
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    Negro F; Clément S
    J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between chronic hepatitis C and type II diabetes mellitus].
    Yang SQ; Chen HS; Jiang D; Wei L; Ji LN; Wang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):46-9. PubMed ID: 12870018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.
    Serfaty L; Poujol-Robert A; Carbonell N; Chazouillères O; Poupon RE; Poupon R
    Am J Gastroenterol; 2002 Jul; 97(7):1807-12. PubMed ID: 12135040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV, hepatitis B and hepatitis C coinfection in Kenya.
    Harania RS; Karuru J; Nelson M; Stebbing J
    AIDS; 2008 Jun; 22(10):1221-2. PubMed ID: 18525268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.